You are here: Home Categories Prostate Cancer
Renal effects of high-dose celecoxib in elderly men with Stage D2 prostate carcinoma - Abstract

Renal effects of high-dose celecoxib in elderly men with Stage D2 prostate carcinoma - Abstract

Published on 09 August 2012
  • Print

Aim: To prospectively study the clinical renal effects of daily high-dose celecoxib, a COX-2 inhibitor, in a cohort of elderly sick men (mean age 74.5 years) with advanced prostate cancer.

To read more, a FREE Urotoday registration is required. Click here to register or login above.
To read UIJ content, a separate subscription is required.
Tags:

Prostate Cancer

caselectures

mehlhaff270

nih role of active surveillance in the management of men with localized prostate cancer

penson sipuleucelX

scardino restaging